nanotechnology biotechnology TSCA
FIFRA
nanotechnology

CHEMICAL PRODUCT DEVELOPMENT AND DEFENSE

biotechnology
TSCA
FIFRA
nanotechnology
ABOUT ACTA EU STAFF ARTICLES NEWS KEY REGULATORY DEVELOPMENTS FAQs CONTACT HOME
biotechnology
nanotech


CHEMICAL PRODUCT DEVELOPMENT AND DEFENSE
A CONSULTING FIRM ESTABLISHED TO CONTROL THE SPIRALING COSTS AND INEFFICIENCIES ENCOUNTERED BY CLIENTS SEEKING APPROVALS TO MARKET CHEMICALS, PRODUCTS OF BIOTECHNOLOGY, NANOTECHNOLOGY, AND MEDICAL DEVICE PRODUCTS. THE ACTA GROUP, L.L.C. MANAGES PRODUCTS FROM CONCEPT TO APPROVAL, UTILIZING THE SKILLS AND EXPERIENCE OF PROFESSIONALS WHO HAVE WORKED IN THE SPECIFIC PRODUCT AREAS IN GOVERNMENT AND INDUSTRY.
TSCA
nanotech
biotech
TSCA

nanotechnology
Acta EU professionals, working closely with their U.S. affiliates, The Acta Group, L.L.C. and Bergeson & Campbell, P.C., offer a full range of REACH regulatory services.

The Acta Group, L.L.C. has been certified as a business owned and controlled by a woman by the National Women Business Owners Corporation (NWBOC).

The Acta Group, L.L.C. has entered into a strategic alliance with RPA to provide targeted REACH services. More information. More information.

nanotech



nanotechnology
The Acta Group, L.L.C. has entered into an exclusive collaborative partnership with Life Plus LLC to provide expertise on Asia's biotechnology-related product registration process.
More information.
 
biotech